Subclavian Vein catheterization_Seldinger Vs Modified Seldinger (MS)
Brain Neoplasm, Intracranial Aneurysm, Cerebrovascular Moyamoya Disease
About this trial
This is an interventional prevention trial for Brain Neoplasm
Eligibility Criteria
Inclusion Criteria:
- patient scheduled for surgery under genearl anesthesia and subclavian vein central catheterization
Exclusion Criteria:
- Patient who does not agree to the study
- Inflammation or infection on catheterization site
- Contralateral diaphragmatic dysfunction
- Anatomic anomalies of subclavian artery or vein/clavicle
- Previous lung surgical history
- Patient who has ventriculoperitoneal shunt or chemoport on same side
- Patient who has pneumo/hemothorax or lung parenchymal disease
Sites / Locations
- Seoul National University of HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
GroupC
Group MS
Group C means Control group which use Seldinger technique for subclavian catheterization. The aimed vessel(subclavian vein) is punctured with a sharp hollow needle, syringe is detached and guidewire is advanced through the lumen of the needle, and the needle is removed. After that catheter is passed over the guidewire into the vessel.
Group MS means experimental group which use modified Seldinger technique for subclavian catheterization. The aimed vessel is punctured with the needle that is covered with guiding sheath. After vessel is punctured, guiding sheath is instatntly slid over the needle into the vessel. The needle is removed, guidewire is advanced through the sheath, central catheter is placed into the vessel.